SI-BONE Investor Relations Material
Latest events
Q1 2025
SI-BONE
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SI-BONE Inc
Access all reports
SI-BONE Inc. is a medical technology company that develops and markets minimally invasive surgical solutions for the treatment of sacroiliac (SI) joint disorders. The company's primary product, iFuse Implant System, is designed to treat conditions such as sacroiliac joint dysfunction and sacroiliitis by providing stabilization and fusion of the SI joint. SI-BONE’s solutions aim to improve patient outcomes and reduce pain for individuals with lower back conditions linked to the SI joint. The company is headquartered in Santa Clara, California, and its shares are listed on the NASDAQ.
Key slides for SI-BONE Inc
Q1 2025
SI-BONE Inc
Q3 2024
SI-BONE Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
SIBN
Country
🇺🇸 United States